Today's Information

Provided by: Center Laboratories, Inc.
SEQ_NO 2 Date of announcement 2022/05/20 Time of announcement 20:40:58
Subject 
 To announce Directors elected by 2022 Annual
Shareholders'Meeting
Date of events 2022/05/20 To which item it meets paragraph 6
Statement 
1.Date of occurrence of the change:2022/05/20
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):
institutional director, independent director, natural-person director
3.Title and name of the previous position holder:
(一) Directors:
(1)Jason Biotech Co., LTD Representative: Lin, Jung Chin
(2)Cheng, Wann-Lai
(3)Chang, Po Chih
(4)Lejean Biotech Co., Ltd.
(5)Witty Mate Corporation
(6)Wechen Co. Ltd.
(7)Po Chang Investment Co., Ltd.
(二) Independent directors:
(1)Ho, Shih-Chinn
(2)Chen, Yung-Chang
(3)Ho, Mei-Yueh
4.Resume of the previous position holder:
（一)Directors:
(1)Lin, Jung Chin: Chairman of Center Laboratories, Inc.
(2)Cheng, Wann-Lai: Chairman of Browave Corp.
(3)Chang, Po Chih: Director of Public Relations Department,
BioGend Therapeutics Co., Ltd.
(4)Lejean Biotech Co., Ltd.: Director of Center Laboratories, Inc.
(5)Witty Mate Corporation: Director of Collins Co., Ltd.
(6)Wechen Co. Ltd.: Director of Center Laboratories, Inc.
(7)Po Chang Investment Co., Ltd.: Director, Chia Her Industrial Co., Ltd.
(二)Independent directors:
(1)Ho,Shih-Chinn:Director of Trade-Van Information Services Co.
(2)Chen,Yung-Chang: Independent Director of Collins Co., Ltd.
(3)Ho,Mei-Yueh:Independent Director of AU Optronics Corp.
5.Title and name of the new position holder:
(一)Directors:
(1)Jason Biotech Co., LTD Representative: Lin, Jung Chin
(2)Lejean Biotech Co., Ltd.
(3)Wechen Co. Ltd.
(4)Po Chang Investment Co., Ltd.
(5)Tsai, Chang-Hai
(6)Chang, Po Chih
(二)Independent directors:
(1)Ho, Mei-Yueh
(2)Ho, Shih-Chinn
(3)LIN SHIRLEY YI-HSIEN
6.Resume of the new position holder:
(一)Directors:
(1)Lin, Jung Chin: Chairman of Center Laboratories, Inc.
(2)Lejean Biotech Co., Ltd.: Director of Center Laboratories, Inc.
(3)Wechen Co. Ltd.: Director of Center Laboratories, Inc.
(4)Po Chang Investment Co., Ltd.: Director, Chia Her Industrial Co., Ltd.
(5)Tsai, Chang-Hai: Chairman of China Medical University Hospital System,
 Taiwan
(6)Chang, Po Chih: Director of Public Relations Department, BioGend
Therapeutics Co., Ltd.
(二)Independent directors:
(1)Ho, Mei-Yueh: Independent Director of AU Optronics Corp.
(2)Ho, Shih-Chinn: Director of Trade-Van Information Services Co.
(3)LIN SHIRLEY YI-HSIEN: Director of SciClone Pharmaceuticals (Holdings)
 Limited.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expire.
8.Reason for the change:Re-election.
9.Number of shares held by the new position holder when elected:
(一)Directors:
(1)Jason Biotech Co., LTD: 10,296,402 shares
Representative: Lin, Jung Chin: 4,197,248 shares
(2)Lejean Biotech Co., Ltd.: 43,719,920 shares
(3)Wechen Co. Ltd.: 4,571,309 shares
(4)Po Chang Investment Co., Ltd.: 57,599 shares
(5)Tsai, Chang-Hai: 0 share
(6)Chang, Po Chih: 1,939,613 shares
(二) Independent directors:
(1)Ho, Mei-Yueh: 0 share
(2)Ho, Shih-Chinn: 0 share
(3)LIN SHIRLEY YI-HSIEN: 0 share
10.Original term (from __________ to __________):
2019/06/24~2022/06/23
11.Effective date of the new appointment:2022/05/20
12.Turnover rate of directors of the same term:
term expired, not applicable.
13.Turnover rate of independent directors of the same term:
term expired, not applicable.
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:None.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Center Laboratories Inc. published this content on 20 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2022 12:44:03 UTC.